loadpatents
name:-0.032363891601562
name:-0.038876056671143
name:-0.00055408477783203
Adams; Jerry L. Patent Filings

Adams; Jerry L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Adams; Jerry L..The latest application filed is for "2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy".

Company Profile
0.39.24
  • Adams; Jerry L. - King of Prussia PA
  • Adams; Jerry L. - Wayne PA
  • Adams, Jerry L - Wayne PA
  • Adams; Jerry L. - N/A
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
Grant 8,058,282 - Adams , et al. November 15, 2
2011-11-15
2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one Compounds And Compositions For Use In Therapy
App 20110046109 - Adams; Jerry L. ;   et al.
2011-02-24
Novel Compounds
App 20110009625 - Adams; Jerry L. ;   et al.
2011-01-13
2,4,5-Trisubstituted pyrimidine compounds
Grant 7,759,486 - Adams , et al. July 20, 2
2010-07-20
Compounds
Grant 7,700,768 - Adams , et al. April 20, 2
2010-04-20
Tetrasubstituted pyrimidine compounds as chemical intermediates
Grant 7,629,462 - Adams , et al. December 8, 2
2009-12-08
Novel Compounds
App 20090105478 - ADAMS; JERRY L. ;   et al.
2009-04-23
Novel compounds
App 20090048442 - Adams; Jerry L. ;   et al.
2009-02-19
Compounds
Grant 7,449,484 - Adams , et al. November 11, 2
2008-11-11
Novel Substituted Imidazole Compounds
App 20080114010 - Adams; Jerry L. ;   et al.
2008-05-15
Novel Compounds
App 20080033170 - Adams; Jerry L. ;   et al.
2008-02-07
Novel Compounds
App 20080032969 - Adams; Jerry L. ;   et al.
2008-02-07
2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds
Grant 7,323,472 - Adams , et al. January 29, 2
2008-01-29
2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds
Grant 7,314,881 - Adams , et al. January 1, 2
2008-01-01
4-amino substituted-6-aryl/heteroaryl substituted-2-methylsulfanyl-pyrimidine-5-carbaldehyde intermediates
Grant 7,314,934 - Adams , et al. January 1, 2
2008-01-01
Substituted imidazole compounds
Grant 7,301,021 - Adams , et al. November 27, 2
2007-11-27
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one Compounds And Their Use In Treating Csbp/p38 Kinase Mediated Diseases
App 20070238743 - Adams; Jerry L. ;   et al.
2007-10-11
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one Compounds And Their Use In Treating Csbp/p38 Kinase Mediated Diseases
App 20070167467 - Adams; Jerry L. ;   et al.
2007-07-19
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
Grant 7,235,551 - Adams , et al. June 26, 2
2007-06-26
Substituted triazole compounds
Grant 7,223,760 - Adams , et al. May 29, 2
2007-05-29
Compounds
Grant 7,189,745 - Adams , et al. March 13, 2
2007-03-13
Novel Compounds
App 20070010534 - Adams; Jerry L. ;   et al.
2007-01-11
Novel compounds
App 20060166988 - Adams; Jerry L. ;   et al.
2006-07-27
3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors
Grant 7,053,098 - Adams , et al. May 30, 2
2006-05-30
3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors
Grant 7,053,099 - Adams , et al. May 30, 2
2006-05-30
3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors
Grant 6,982,270 - Adams , et al. January 3, 2
2006-01-03
Novel Compounds
App 20050203109 - Adams, Jerry L. ;   et al.
2005-09-15
3,4-Dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
App 20050075352 - Adams, Jerry L. ;   et al.
2005-04-07
Pyridin-4-YL or pyrimidin-4-YL substituted pyrazines
Grant 6,861,417 - Adams , et al. March 1, 2
2005-03-01
Substituted imidazole compounds
Grant 6,858,617 - Adams February 22, 2
2005-02-22
Novel compounds
App 20040209901 - Adams, Jerry L. ;   et al.
2004-10-21
Pyrazole and pyrazoline substituted compounds
Grant 6,774,127 - Adams , et al. August 10, 2
2004-08-10
3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
Grant 6,759,410 - Adams , et al. July 6, 2
2004-07-06
Novel compounds
App 20040116697 - Adams, Jerry L. ;   et al.
2004-06-17
Novel compounds
App 20040053943 - Adams, Jerry L. ;   et al.
2004-03-18
Pyridin-4-YL or pyrimidin-4-YL substituted pyrazines
App 20040014973 - Adams, Jerry L. ;   et al.
2004-01-22
Novel substituted imidazole compounds
App 20040002509 - Adams, Jerry L.
2004-01-01
Novel substituted triazole compounds
App 20030229110 - Adams, Jerry L. ;   et al.
2003-12-11
Aryloxy substituted pyrimidine imidazole compounds
Grant 6,610,695 - Adams , et al. August 26, 2
2003-08-26
Novel pyrazole and pyrazoline substituted compounds
App 20030153569 - Adams, Jerry L. ;   et al.
2003-08-14
Substituted triazole compounds
Grant 6,599,910 - Adams , et al. July 29, 2
2003-07-29
Novel substituted imidazole compounds
App 20030114452 - Adams, Jerry L. ;   et al.
2003-06-19
1,5- disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
App 20030100756 - Adams, Jerry L ;   et al.
2003-05-29
Substituted imidazoles having anti-cancer and cytokine inhibitory activity
Grant 6,548,520 - Adams , et al. April 15, 2
2003-04-15
Novel substituted imidazole compounds
App 20030069243 - Adams, Jerry L. ;   et al.
2003-04-10
Substituted imidazole compounds
Grant 6,489,325 - Adams , et al. December 3, 2
2002-12-03
Novel Pyrazole And Pyrazoline Substituted Compounds
App 20020156104 - ADAMS, JERRY L. ;   et al.
2002-10-24
Substituted imidazole compounds
Grant 6,046,208 - Adams , et al. April 4, 2
2000-04-04
Substituted imidazole compounds
Grant 5,977,103 - Adams , et al. November 2, 1
1999-11-02
Polynucleotides encoding cytokine suppressive anti-inflammatory drug binding proteins
Grant 5,955,366 - Lee , et al. September 21, 1
1999-09-21
Cycloalkyl substituted imidazoles
Grant 5,929,076 - Adams , et al. July 27, 1
1999-07-27
Cytokine suppressive anit-inflammatory drug binding proteins
Grant 5,783,664 - Lee , et al. July 21, 1
1998-07-21
Oligonucleotides comprising a region of a cytokine suppressive anti-inflammatory drug binding protein
Grant 5,777,097 - Lee , et al. July 7, 1
1998-07-07
Substituted imidazole compounds
Grant 5,756,499 - Adams , et al. May 26, 1
1998-05-26
Substituted imidazole compounds
Grant 5,716,955 - Adams , et al. February 10, 1
1998-02-10
Compounds
Grant 5,593,992 - Adams , et al. January 14, 1
1997-01-14
Imidazole compounds, use and process of making
Grant 5,593,991 - Adams , et al. January 14, 1
1997-01-14
Compounds
Grant 5,559,137 - Adams , et al. September 24, 1
1996-09-24
Anti-inflammatory compounds
Grant 5,545,669 - Adams , et al. August 13, 1
1996-08-13
Anti-inflammatory compounds
Grant 5,447,957 - Adams , et al. September 5, 1
1995-09-05
Pyrrolo [1,2-a] imidazole and imidazo [1,2a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
Grant 5,145,858 - Adams , et al. September 8, 1
1992-09-08
Steroidal 14.alpha.-carboxy-alkyl derivatives as regulators of HMG-COA reductase
Grant 5,023,250 - Adams , et al. June 11, 1
1991-06-11
Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
Grant 5,002,941 - Adams , et al. March 26, 1
1991-03-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed